Coronary angioplasty: results with expanded indications

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
• Assessing the long-term efficacy and safety of PTCA is crucial for patient management.

Purpose of the Study:

• To evaluate the primary success rates, major acute complications, and long-term clinical outcomes of percutaneous transluminal coronary angioplasty.
• To analyze the effectiveness of PTCA in specific patient subgroups, including multivessel disease, chronic total occlusions, evolving myocardial infarction, and repeat procedures.

Main Methods:

• A retrospective review of 600 consecutive percutaneous transluminal coronary angioplasty procedures in 530 patients.
• Clinical follow-up and control angiography were performed at 12 ± 6 months post-procedure.
• Analysis of primary success, complication rates, and New York Heart Association (NYHA) functional class improvement.

Main Results:

• Primary success rate was 87% per patient, with major acute complications in 10% of patients (including 2 deaths).
• At 12-month follow-up, 82% of patients with primary success showed improvement in NYHA functional class.
• Subgroup analysis revealed varying success and recurrence rates: multivessel angioplasty (87% success, 41% recurrence), chronic total occlusion (56% success, 48% recurrence), evolving myocardial infarction (84% success, 23% recurrence), and repeat angioplasty (90% success, 48% recurrence).

Conclusions:

• Percutaneous transluminal coronary angioplasty, including repeat procedures, achieves a long-term clinical success rate of approximately 80%.
• PTCA demonstrates significant improvement in functional capacity for a majority of patients, with notable variations in outcomes across different clinical scenarios.